Molecular targeting by homocysteine: a mechanism for vascular pathogenesis.
Hyperhomocysteinemia is an independent risk factor for cardiovascular disease. Although there is a growing body of evidence that homocysteine plays a causal role in atherogenesis, specific mechanisms to explain the underlying pathology have remained elusive. This review focuses on chemistry unique to the homocysteine molecule to explain its inherent cytotoxicity. Thus, the high pKa of the sulfhydryl group (pKa=10.0) of homocysteine underlies its ability to form stable disulfide bonds with protein cysteine residues, and in the process, alters or impairs the function of the protein. Albumin, fibronectin, transthyretin, annexin II, and factor V have now been identified as molecular targets for homocysteine, and in the case of albumin, the mechanism of targeting has been elucidated.
Jacobsen
Donald W
DW
Department of Cell Biology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, USA. jacobsd@ccf.org
Catanescu
Otilia
O
Dibello
Patricia M
PM
Barbato
John C
JC
D000818:Animals; D001798:Blood Proteins / Q000378:metabolism; D042783:Endothelial Cells / Q000378:metabolism; D006710:Homocysteine / Q000737:chemistry / Q000378:metabolism*; D006801:Humans; D008565:Membrane Proteins / Q000378:metabolism; D014652:Vascular Diseases / Q000378:metabolism* / Q000473:pathology*
D001798:Blood Proteins; D008565:Membrane Proteins; D006710:Homocysteine